1. "2016"
Formats
  1. Journal Article (2949)
  2. Meeting Abstract (1606)
  3. Book Section (155)
  4. Conference Paper (36)
  5. Book Whole (14)
Groups
  1. Department of Medicine (1963)
  2. GSK Faculty (1162)
  3. Solid Tumor Oncology Division (1064)
  4. Surgery (904)
  5. Survivorship Research (795)
  6. Center for Hematologic Malignancies (777)

More Groups

People
  1. Michael Berger (93)
  2. Jedd Wolchok (84)
  3. Robert Motzer (74)
  4. Sergio Giralt (73)
  5. Miguel-Angel Perales (69)
  6. Jose Baselga (67)

More People

Years
  1. 2016 (4760)
Publications
  1. Journal of Clinical Oncology (469)
  2. Blood (210)
  3. Modern Pathology (124)
  4. Laboratory Investigation (108)
  5. International Journal of Radiation Oncology, Biology, Physics (104)
  6. Annals of Oncology (94)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (497)
  3. Springer (349)
  4. Nature Publishing Group (322)
  5. Oxford University Press (248)
  6. American Society of Hematology (213)

More Publishers

Results (4760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transgenic drosophila as a drug-screening platform in colorectal cancer and medullary thyroid cancer
    Meeting Abstract

    Rozehnal, J. M.; Posner, M. R.; Ang, C.; Bangi, E.; Yeykal, C.; Cagan, R. L.; Dang, R. P.; Donovan, M.; Uzilov, A. V.; Antipin, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical outcomes in genetically targeted cancer treatment
    Meeting Abstract

    Rozehnal, J. M.; Ang, C.; Donovan, M.; Bangi, E.; Yeykal, C.; Cagan, R. L.; Antipin, Y.; Uzilov, A. V.; Posner, M. R.; Misiukiewicz, K.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Do pancreatic cancer (PDA) stem cell markers predict biologic behavior?
    Meeting Abstract

    Sahin, I. H.; Turkekul, M.; Capanu, M.; Askan, G.; McMahon, B.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Rosenberg, J. E.; Heath, E. I.; Van Veldhuizen, P. J.; Merchan, J. R.; Lang, J. M.; Ruether, J. D.; Petrylak, D. P.; Sangha, R. S.; Smith, D. C.; Sridhar, S. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children's Oncology Group ARAR0332 protocol
    Meeting Abstract

    Rodriguez-Galindo, C.; Pappo, A. S.; Krailo, M. D.; Pashankar, F.; Caran, E. M. M.; Hicks, J.; McCarville, M. B.; Weldon, C. B.; Malkin, D.; Zambetti, G.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Three-year overall survival for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
    Meeting Abstract

    Robert, C.; Ribas, A.; Hamid, O.; Daud, A.; Wolchok, J. D.; Joshua, A. M.; Hwu, W. J.; Weber, J. S.; Gangadhar, T. C.; Joseph, R. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210)
    Meeting Abstract

    Rosenberg, J. E.; Petrylak, D. P.; Van Der Heijden, M. S.; Necchi, A.; O'Donnell, P. H.; Loriot, Y.; Retz, M.; Perez-Gracia, J. L.; Bellmunt, J.; Grivas, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Rose, T. L.; Ladoire, S.; Crehange, G.; Galsky, M. D.; Rosenberg, J. E.; Bellmunt, J.; Powles, T.; Wong, Y. N.; Harshman, L. C.; Chowdhury, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Expression levels of aldehyde dehydrogenase 1A1 (ALDH1A1) in circulating tumor and invasive cells (CTICs) as a biomarker for drug resistance and disulfiram in pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Ricigliano, M.; Cooper, B.; Ocean, A. J.; Tiriac, H.; Tuveson, D. A.; Yu, K. H.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Association of outcomes and co-occuring genomic alterations in patients with KRAS-mutant non-small cell lung cancer
    Meeting Abstract

    Riely, G.; Jordan, E.; Kim, H. R.; Yu, H. A.; Berger, M. F.; Solit, D. B.; Kris, M. G.; Ni, A.; Arcila, M. E.; Ladanyi, M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save